Chey W D, Kochman M L, Traber P G, Appelman H D, Gumucio J J
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA.
J Clin Gastroenterol. 1995 Mar;20(2):164-7. doi: 10.1097/00004836-199503000-00022.
Subfulminant hepatic failure has not been reported to occur with the histamine-2 receptor antagonists. We report a possible case of nizatidine-induced subfulminant hepatic failure leading to the eventual development of cirrhosis.
尚未有关于组胺-2受体拮抗剂导致亚急性肝衰竭的报道。我们报告了一例可能由尼扎替丁引起的亚急性肝衰竭病例,该病例最终发展为肝硬化。